[Contribution of angioxine to the vascular protection of the diabetic].
D000818:Animals; D002219:Carbamates / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000150:complications; D003327:Coronary Disease / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000188:drug therapy; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy; D051379:Mice; D008833:Microcirculation / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011727:Pyridinolcarbamate / Q000494:pharmacology / Q000627:therapeutic use*
D002219:Carbamates; D011727:Pyridinolcarbamate
Apport de l'Angioxine dans la protection vasculaire du diabétique